Amirabbas Parizadeh, PhD
Postdoctoral fellow
Amirabbas received his PhD in Molecular and Cellular Biology of Diseases from the Medical University of Innsbruck where he studied actin dynamics and cell migration of breast cancers cells. In the Rosenbluth lab, he is conducting research to elucidate new therapeutic targets in triple-negative breast cancers and malignant effusions.
Nadine Goldhammer, PhD
Postdoctoral fellow
Nadine received her PhD in Molecular Mechanisms of Disease from the University of Copenhagen, where she studied the cellular composition of the mammary gland. In the Rosenbluth lab, she will use single-cell technologies to investigate pre-cancerous lesions in the human breast to understand how cancer risk factors such as aging contribute to tumorigenesis.
Jie (Lily) Zeng, MD, PhD
Postdoctoral fellow
Lily received her MD in Clinical Medicine at Nanchang University and PhD in Internal Medicine at Tongji University. She conducted lung cancer translational research as a visiting scholar / postdoc at UC Davis. In the Rosenbluth Lab, she’s excited to model inflammatory breast cancer (IBC) and find novel solutions for breast cancer treatment.
Liana Beld, MS
Specialist
Liana received her Master of Science in Global Health Sciences from UCSF with a focus on drug discovery for Neglected Tropical Diseases. In the Rosenbluth Lab, she will use single cell analysis techniques to study early events in breast cancer development.
Kirithiga Ramalingam, MD
Postdoctoral research fellow
Kirithiga is a breast surgeon currently performing her research fellowship and working with Dr. Laura Esserman, Dr. Rosenbluth, and a multi-disciplinary team to develop new treatment strategies for Ductal Carcinoma in Situ that both avoid over-treatment and prevent the development of lethal invasive disease.
Shruti Warhadpande, MS
Specialist
Shruti Warhadpande received her Master of Science in Biomedical Engineering from The University of Texas. She then went on to work as an Assistant Research Scientist at New York University for 5 years where her expertise was in developing point-of-care diagnostic tests for the detection of Oral Cancer Biomarkers, Cardiac Biomarkers, and Drugs of Abuse. In the Rosenbluth lab she will develop organoid-based assays and the breast tissue biobank.
Michael Bruck, BS
Specialist
Michael has previously worked with tissue samples in an office for the continuation of education for medical professionals and testing of new medical devices. He's excited to assist in setting up the breast organoid pipeline at UCSF in order to develop new strategies for breast cancer prevention.
Tam Binh Bui, MSc, MD
Graduate Student
Tam Binh Bui is a PhD student at Utrecht University, The Netherlands, and a visiting graduate student at UCSF. She is working with Dr. Laura van ‘t Veer and Dr. Rosenbluth to study biomarker signatures predicting treatment response/resistance in early-stage breast cancer and develop new strategies to overcome therapeutic resistance in breast cancer.
Joining our team part-time are Breast Oncology Program interns and clinical research coordinators including Allison Lam and Cristian Maldonado Rodas, both of whom are interested in patient-oriented breast cancer research.